Shares of Johnson & Johnson
JNJ,
+0.11%
inched 0.11% higher to $177.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
SPX,
+0.59%
rising 0.59% to 4,027.26 and the Dow Jones Industrial Average
DJIA,
+0.28%
rising 0.28% to 34,194.06. This was the stock’s second consecutive day of gains. Johnson & Johnson closed $9.68 short of its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert.
RHHVF,
+1.89%
rose 1.89% to $323.42, Merck & Co. Inc.
MRK,
-0.07%
fell 0.07% to $106.82, and Pfizer Inc.
PFE,
-0.47%
fell 0.47% to $48.85. Trading volume (5.4 M) remained 1.8 million below its 50-day average volume of 7.2 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
